Walter J Urba

5PUBLICATIONS
52CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 12, 2024
Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health System.

Alexa K Dowdell, Ryan C Meng, Ann Vita

|May 15, 2024
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Timothy L Cannon, Michael Rothe, Pam K Mangat

|Dec 14, 2023
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Funda Meric-Bernstam, Michael Rothe, Pam K Mangat

|Apr 11, 2023
Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies.

Bernard A Fox, Walter J Urba, Shawn M Jensen

|Sep 27, 2022
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.

Michael B Atkins, Sandra J Lee, Bartosz Chmielowski

Pageof 1

Frequent Collaborators

2 joint publications

Timothy L Cannon

2 joint publications

Susan Halabi

2 joint publications

Gina N Grantham

2 joint publications

Elizabeth Garrett-Mayer